Efferent Labs at NYBio 2018

Efferent Labs at NYBio 2018

FOR IMMEDIATE RELEASE

Efferent Labs™ at 2018 NewYorkBIO

(BUFFALO, NY) April 24, 2016 – Efferent Labs will present the CytoComm™ Biosensor
Platform at the NYBio Annual Conference in New York City on May 15, 2018 at 10 on the
Park @ Time Warner Center. The company will discuss the CytoComm™ Living Biosensor
System and its innovative technology, and updates on research and development. In
addition, the company will address the value of CytoComm™ as a platform technology
with multiple applications including preclinical R&D, clinical testing, oncology,
cardiology, and metabolic monitoring.

More information about Efferent Labs™ can be found at www.efferentlabs.com

ABOUT EFFERENT LABS™:
Efferent Labs™ is a developer of high value medical diagnostic technology. Efferent Labs’
proprietary technology, the CytoComm™ Living Cell Biosensor System, is a platform
used for in vivo, real-time monitoring of biological signaling and cellular response. The
company is based in Buffalo, NY and is a 2014 43North award winner and 2015 Verizon
Powerful Answers semi-finalist.
FOR MORE INFORMATION CONTACT: press@efferentlabs.com

ABOUT NYBio:
The NewYorkBIO 2018 annual conference will be held Wednesday May 16 – Thursday
May 17, 2018 at the Time Warner Center, 60 Columbus Circle, New York NY.
NewYorkBIO supports the development and growth of New York State’s life science
industry and serves its members and the life science community by providing a network
for public policy, industry advocacy, and community development. For further
information, please visit newyorkbio.org.
###